CLINICAL_TRIALS
ClinicalTrials.gov record update
Ipilimumab and Gemcitabine for Advanced Pancreas Cancer: A Phase Ib Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01473940
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:47.550882+00:00
- Published At
- 2020-03-06T00:00:00+00:00
- Record Updated At
- 2020-03-06
- Results Posted At
- 2020-03-06
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Duct Cell Adenocarcinoma of the Pancreas", "Recurrent Pancreatic Cancer", "Stage III Pancreatic Cancer", "Stage IV Pancreatic Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-03-06"- protocolSection.identificationModule.nctId
"NCT01473940"- protocolSection.identificationModule.officialTitle
"Ipilimumab and Gemcitabine for Advanced Pancreas Cancer: A Phase Ib Study"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-03-06"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.